-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
Eagle Pharmaceuticals, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2012 to 2022.
- Eagle Pharmaceuticals, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2023 was $12.6M.
- Eagle Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$6.21M, a 78.1% increase from 2021.
- Eagle Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was -$28.4M, a 25% increase from 2020.
- Eagle Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2020 was -$37.9M, a 56.3% decline from 2019.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)